In this study, we unexpectedly found that in tumor cells that lack rhythmic gene expression, CR regulator REV-ERBα switches its function from repressor to a master activator in direct control of multiple tumorigenic programs including MAPK and PI3K-Akt signaling. The gene discussed is NR1D1; the disease is neoplasm.